Similarly, CAR-NK cells targeting PD-L1 were able to effectively kill ATC and MTC cells, which typically express high levels of PD-L1, demonstrating their potential to overcome tumor immune evasion [33]. This evidence concerns the gene CD274 and neoplasm.